Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2017 Jul;65(1):53–57. doi: 10.1097/MPG.0000000000001415

Lack of Knowledge and Low Readiness for Healthcare Transition in Eosinophilic Esophagitis and Eosinophilic Gastroenteritis

Swathi Eluri 1, Wendy M Book 2, Ellyn Kodroff 3, Mary Jo Strobel 2, Jessica H Gebhart 1, Patricia D Jones 4, Paul Menard-Katcher 5, Maria E Ferris 6, Evan S Dellon 1
PMCID: PMC5360549  NIHMSID: NIHMS816488  PMID: 28644350

Abstract

Objectives

A growing population of adolescents/young adults with eosinophilic esophagitis (EoE) and eosinophilic gastroenteritis (EGE) will need to transition from pediatric to adult health providers. Measuring healthcare transition (HCT) readiness is critical, but no studies have evaluated this process in EoE/EGE. We determined the scope and predictors of HCT knowledge in patients and parents with EoE/EGE and measured HCT readiness in adolescents/young adults.

Methods

We conducted an online survey of patients ≥13 years and parents of patients with EoE/EGE who were diagnosed when ≤25 years of age. Parents answered questions regarding their children and their own knowledge of HCT. HCT readiness was assessed in adolescents/young adults aged 13-25 years with the Self-Management and Transition to Adulthood with Rx (STARx) Questionnaire (a six domain self-report tool) with a score range of 0-90.

Results

450 participants completed the survey: 205 patients and 245 parents. Included in the analysis (those diagnosed with EoE/EGE at age ≤25 years) were 75 of 205 patients and children of 245 parent respondents. Overall, 78% (n=52) of the patients and 76% (n=187) of parents had no HCT knowledge. Mean HCT readiness score in adolescents/young adults (n=50) was 30.4±11.3 with higher scores in domains of provider communication and engagement during appointments. Mean parent-reported (n=123) score was 35.6±9.7 with higher scores in medication management and disease knowledge.

Conclusions

There was a significant deficit in HCT knowledge, and HCT readiness scores were lower than other chronic health conditions. HCT preparation and readiness assessments should become a priority for adolescents/young adults with EoE/EGE and their parents.

Keywords: eosinophilic esophagitis, eosinophilic gastroenteritis, healthcare transition readiness

INTRODUCTION

Eosinophilic esophagitis (EoE) and eosinophilic gastroenteritis (EGE) are chronic, immune mediated conditions (1-5) affecting both children and adolescents/young adults (6-9). While the natural history of these diseases is not well understood, there is evidence (10) that children with EoE continue to be symptomatic as they transition to adulthood and require ongoing therapy and chronic disease management. Our clinical experience is that the same is true of EGE.

Healthcare transition (HCT) is the “purposeful, planned movement of adolescents and young adults with chronic physical and medical conditions from child-centered to adult-oriented health care systems” (11, 12). The key to successful HCT is to accurately measure HCT readiness to determine the most optimal time and mode of transitioning to an adult provider (13). HCT needs in adolescents with chronic conditions has been recognized and studied to facilitate development of needs-based HCT programs (14-18). However, there are certain health conditions such as EoE/EGE in which HCT needs have not been well described (19) or formally assessed in a population with high disease burden.

Therefore, we aimed to assess whether EoE/EGE patients and parents of patients with these conditions had knowledge of HCT, and to determine the scope and predictors of HCT knowledge. The secondary aim was to measure HCT readiness in adolescents/young adults with EoE/EGE using the Self-Management and Transition to Adulthood with Rx (STARx) Questionnaire (13, 20) and to correlate it with factors impacting transition readiness.

METHODS

Study Design and Population

This was a cross-sectional survey of patients who were ≥13 years old with EoE/EGE or parents of EoE/EGE patients of all ages. Of note, these were not parent-child pairs. Using the Qualtrics™ web-based platform, we deployed an online survey through the American Partnership for Eosinophilic Disorders (APFED) and Campaign Urging Research for Eosinophilic Disease (CURED) websites, email lists, social media sites, and other online resources. Two versions of the survey were administered: patient-reported and parent-reported. Patients answered the questions themselves. Parents were requested to answer questions regarding their children and their own familiarity with HCT. The study was approved by the University of North Carolina Institutional Review Board prior to study initiation and informed consent/assent was obtained from all study participants.

STARx Healthcare Transition Readiness (HCTR) Assessment

All participants completed a STARx Questionnaire (13) to assess readiness to transition from pediatric to adult health care services. Patients completed the survey by answering questions about their own HCT readiness and parents regarding perceived HCT readiness of their children. The STARx Questionnaire measures self-reported HCT readiness and self-management for adolescents/young adults with chronic health conditions. The development, reliability, and validity of the tool have been described previously (13, 20). In brief, the STARx Questionnaire comprises of 18 questions measured on a 5-point Likert scale and measures HCT readiness in six domains, including medication management, provider communication, engagement during appointments, disease knowledge, adult health responsibilities, and resource utilization. The questionnaire is scored from 0-90, with higher scores indicating higher levels of HCT readiness.

Statistical Analysis

Descriptive statistics were used to summarize characteristics of the study population. Bivariate analyses were used to compare those who did and did not have prior knowledge of HCT in the subset of patients diagnosed with EoE/EGE when ≤25 years. Student's t test and Wilcoxon rank sum were used for continuous variables and Pearson χ2 test was used for categorical variables. HCT readiness analysis using the STARx Questionnaire was restricted to adolescents/young adults aged 13-25 years as it was validated in this age group (13, 20). Analysis of the parent-reported survey was similarly restricted to those who had children with EoE/EGE aged 13-25 years. Mean HCT readiness in each of the six domains and mean total HCT readiness scores were calculated from both the patient and parent surveys. Differences between the parents’ perceptions of their children's readiness and patient self-reported readiness were compared using Student's t test. Association between HCT readiness scores and patient and provider characteristics were calculated and differences in scores within each domain with increasing age groups were also calculated using analysis of variance. Differences were considered statistically significant at an alpha level <0.05. All analyses were performed using STATA 13 (StataCorp, College Station, TX).

RESULTS

A total of 450 participants completed the survey: 205 patients and 245 parents. We restricted the analysis to those diagnosed with EoE/EGE at age ≤25 years, resulting in a sample of 75 patients and all 245 children of parent respondents. A majority in both groups had EoE (Table 1). Among those who took the patient survey, 20% were male compared to the parent survey in which 70% of the children with EoE/EGE were male. In the patient survey, median age (23 ± 7 vs. 12 ± 6) and age of disease onset (16 ± 6 vs. 8 ± 5) was higher, and a larger proportion had active symptoms (92% vs. 77%) compared to the children of parents who took the parent survey. Approximately 80% of the subjects with EoE/EGE in both groups were on active dietary therapy for disease management. A very high proportion from both groups was under the active care of a primary care provider (PCP) (84% vs. 97%), a gastroenterologist (GI) (85% vs. 92%), a nutritionist (69% vs. 71%), and an allergist (84% vs. 89%).

Table 1.

Participant Characteristics

Patient survey (n=75) Parente survey (n=245)
Disease Type, n (%)
    EoEa 57 (78) 193 (79)
    EGEb 6 (8) 17 (7)
    Both 12 (16) 35 (14)
Male, n (%) 15 (20) 172 (70)
Age, mean yrs ± SD 23 ± 7 12 ± 6
Age at diagnosis, mean yrs ± SD 16 ± 6 8 ± 5
Active symptoms, n (%) 69 (92) 188 (77)
Active steroid use, n (%) 38 (51) 102 (44)
Active dietary elimination, n (%) 63 (84) 193 (82)
Current primary care provider (PCP), n (%) 62 (84) 225 (97)
Type of primary care provider, n (%)
    Pediatrician 16 (26) 154 (68)
    Internal medicine 45 (60) 39 (17)
    Other health professional 40 (15) 32 (14)
Current GIc provider, n (%) 63 (85) 214 (92)
Type of GI provider, n (%)
    Pediatric GI 28 (44) 197 (92)
    Adult GI 35 (56) 17 (8)
Nutritionist, n (%) 51 (69) 165 (71)
Allergist, n (%) 62 (84) 207 (89)
Lack of HCTd Knowledge, n (%) 52 (78) 187 (76)
a

Eosinophilic esophagitis

b

Eosinophilic gastroenteritis

c

Gastroenterologist

d

Healthcare transition

e

Parents answered questions regarding their children and their own knowledge of healthcare transition

Overall, 78% (n=52) of the patients and 76% (n=187) of parents reported having no prior knowledge of HCT. Factors associated with lack of HCT knowledge among patients were older age (24 vs. 19 years, p=0.03), older age at disease diagnosis (17 vs. 12 years, p<0.01), and already seeing an adult gastroenterologist (63% vs. 38%, p<0.05) (Table 2). Few factors were associated with parental unfamiliarity with HCT other than active steroid use. For example, parents who had children with EoE/EGE and who were on active steroid treatment were less likely to know about HCT (48% vs. 31%, p=0.03). Knowledge regarding HCT was not associated with a difference in preferred age to discuss or initiate the transition process. Interestingly, the mean preferred age to initiate HCT was at least 18 in all groups and the highest preferred age of 24 years was in participants taking the patient survey who were familiar with HCT (Table 2).

Table 2.

Association of Patient and Provider Characteristics and Familiarity with HCTa in Patients and Parents of Patients with Eosinophilic Esophagitis and Eosinophilic Gastroenteritis

Patient survey (n=67) Parentf survey (n=245)

Familiar with HCT (n=15) Unfamiliar with HCT (n=52) p value Familiar with HCT (n=58) Unfamiliar with HCT (n=187) p value
Disease Type, n (%) 0.09 0.39
    EoEb 9 (60) 42 (81) 42 (72) 151 (81)
    EGEc 3 (20) 2 (4) 5 (9) 12 (6)
    Both 3 (20) 8 (15) 11 (19) 24 (13)
Male, n (%) 3 (20) 10 (19) 0.95 43 (74) 129 (69) 0.45
Female, n (%) 12 (80) 42 (71) 15 (26) 58 (31)
Age, mean yrs ± SD 19 ± 4 24 ± 7 0.03 13 ± 5 12 ± 6 0.07
Age at diagnosis, mean yrs ± SD 12 ± 5 17 ± 6 <0.01 8 ± 5 7 ± 5 0.63
Active symptoms, n (%) 14 (93) 47 (90) 0.72 55 (95) 175 (94) 0.73
Active steroid use, n (%) 7 (47) 31 (60) 0.37 18 (31) 84 (48) 0.03
Active dietary elimination, n (%) 14 (93) 43 (83) 0.31 52 (90) 141 (80) 0.10
Percent of life with disease 0.41 0.32
    ≤50 3 (2) 6 (12) 27 (47) 73 (39)
    >50 12 (80) 45 (88) 31 (53) 113 (61)
PCPd, n (%) 0.75 0.06
    Pediatrician 4 (29) 12 (26) 32 (56) 122 (73)
    Internal medicine 9 (64) 28 (60) 13 (23) 26 (15)
    Other health professional 1 (7) 7 (15) 12 (21) 20 (12)
GIe provider, n (%) <0.05 0.72
    Pediatric GI 10 (67) 18 (38) 50 (91) 147 (92)
    Adult GI 5 (33) 30 (63) 5 (9) 12 (8)
Preferred age to initiate HCT discussion, mean yrs ± SD 20 ± 8 18 ± 6 0.27 19 ± 7 18 ± 6 0.51
Preferred age to initiate HCT, mean yrs ± SD 24 ± 10 20 ± 4 0.12 21 ± 7 20 ± 6 0.09
a

Healthcare transition

b

Eosinophilic esophagitis

c

Eosinophilic gastroenteritis

d

Primary care provider

e

Gastroenterologist

f

Parents answered questions regarding their children and their own knowledge of healthcare transition

The proportion of participants who reported knowledge of HCT between the ages of 0-25 years were calculated divided into 5 age groups (Supplementary Figure). Among those who took the patient survey, only about half of those aged between 16 to 20 years were familiar with HCT. The largest percent of parents who were familiar with HCT had children aged 11-15, but this was still under 50%. HCT knowledge was similarly low among parents with children aged 0-10 and 15-25 years.

Healthcare Transition Readiness

Out of 50 subjects aged 13-25 and 123 parents of patients in this age range, mean HCT readiness score was 30.4 ± 11.3 with scores in domains of provider communication, disease knowledge, and engagement during appointments being somewhat higher than other domains (Table 3). Mean parent-reported HCT readiness score was 35.6 ± 9.7 with higher scores in the domains of medication management and disease knowledge and lower scores in the adult health responsibilities and resource utilization domains. Overall, there was a significant difference in parent-reported HCT readiness scores and patient-reported scores across all domains except for disease knowledge and adult health responsibilities. Parent-reported readiness of their children in the domains of provider communication (8.2 vs 5.8, p<0.01), engagement during appointments (9.7 vs 5.4, p<0.01), and resource utilization (6.3 vs 4.4, p<0.01) was significantly lower than patient-reported readiness. For medication management, patient-reported readiness scores were lower than the parent-reported scores for their children (6.5 vs. 8.8, p<0.01).

Table 3.

Health Care Transition Readiness Scoresa using the STARxb Questionnaire in Adolescents/Young Adults with Eosinophilic Esophagitis and Eosinophilic Gastroenteritis

Domains of STARx Questionnaire for Transition Readiness Patient Survey (n) Mean Patient Score ± SD Parentc Survey (n) Mean Parent Score ± SD p value
Medication Management 47 6.5 ± 2.5 112 8.8 ± 1.6 <0.01
Provider Communication 40 8.2 ± 3.1 108 5.8 ± 3.2 <0.01
Engagement during appointments 50 9.7 ± 2.6 109 5.4 ± 2.2 <0.01
Disease Knowledge 44 7.8 ± 1.5 111 7.6 ± 1.6 0.48
Adult Health Responsibilities 44 3.7 ± 1.6 110 4.1 ± 2.1 0.26
Resource Utilization 50 6.3 ± 3.0 111 4.4 ± 3.0 0.01

Total Score 47 30.4 ± 11.3 112 35.6 ± 9.7 <0.01
a

Scores range from 0 to 90 with 0 indicating lowest health care transition readiness

b

Self-Management and Transition to Adulthood with Rx

c

Parents answered questions regarding their children's perceived healthcare transition readiness

There was no association between overall HCT readiness score and disease type, age, age at diagnosis, percent of life with disease, active symptoms, active steroid use, dietary therapy, or provider type (Supplementary Table 1). When adolescents/young adults were divided into age groups (13-15, 16-18, 19-21 and 22-25 years of age) based on developmental milestones, there were no significant differences between HCT readiness scores among the different age groups within each domain other than adult health responsibilities and engagement during appointments (Supplementary Table 2). Interestingly, participants taking the patient survey who were 22-25 had lower readiness scores than those in the 13-15 age group in the domain of adult health responsibilities (2.8 vs. 4.7, p=0.01). In the parent survey, there was a statistically significant increase in perceived transition readiness of their children with increasing age in the domain of engagement during appointments (7.5 vs 5.0, p=0.01).

DISCUSSION

Our study is the only of its kind to assess HCT knowledge and readiness in EoE/EGE. Knowledge of healthcare transition was lacking in more than 75% of the participants, and this lack of HCT knowledge was similar in patients with EoE/EGE and in parents of patients with these conditions. This is a significant deficit in knowledge, particularly as this survey was conducted among a group of subjects connected to patient advocacy groups and support websites, who were likely highly motivated. Among parents, age of the children did not correlate with transition knowledge. In fact, a similar proportion of parents who had children aged 0-10 years reported being familiar with HCT as those who had children aged 15-25. In addition, HCT readiness scores measured with the validated STARx Questionnaire were notable low in adolescents/young adults with EoE/EGE. Overall, there was no correlation between overall HCT readiness scores and disease type, markers of disease severity, age, disease duration, or provider type.

When comparing EoE/EGE to other chronic diseases, we were not able to make a valid comparison of the lack of HCT knowledge because HCT knowledge can be assessed in multiple ways. However, the preferred age for HCT of 18 years in both patients and parents reported in our sample is similar to those of other non-GI chronic diseases (21) and inflammatory bowel disease (IBD) (22, 23). Even though pediatric societies recommend ages closer to 12 for HCT initiation (24), the age of 18 is likely seen by patients and parents as a more practical choice as it coincides with a social transition to secondary schooling such as college (25). Another similarity was that the higher readiness scores in domains such as “provider communication” and “engagement during appointments” seen in our EoE/EGE population were also areas of higher mastery in the IBD population (26). One major difference was that the mean scores for HCT readiness were considerably lower in EoE/EGE compared to other chronic disease conditions (13). In a sample comprised primarily of adolescents/young adults with other chronic conditions (chronic kidney disease, IBD, cystic fibrosis, and systemic lupus erythematous) mean HCT readiness scores measured by the STARx Questionnaire ranged from 43 to 59 with an increase in readiness scores with increasing age of the participants (13).

One of the reasons for lower HCT readiness in EoE/EGE compared to other chronic conditions could be due to lack of HCT knowledge. Three quarters of a highly motivated group of EoE/EGE patients and parents in this study lacked HCT knowledge, and this is markedly higher than has been reported in other conditions (27). There are also provider reported barriers to HCT that have been identified (23) since the process of HCT is a collaborative effort between patients, caretakers, and healthcare providers. Provider perceived barriers to HCT such as lack of infrastructure, disease knowledge, and training in adolescent care (23, 28) have not been assessed in EoE/EGE and would be a valuable perspective to ascertain in future studies.

HCT needs to be prioritized because of the increasing incidence and prevalence of EoE (7). Studies have shown that the prevalence of EoE decreases after age 45 and a majority affected is children and adolescents/young adults (9, 29, 30). For EGE, the overall prevalence is lower compared to EoE, but EGE is most commonly diagnosed in children aged <5 years (4). As a result, there will likely be a large influx of EoE/EGE patients who will need to transition to adult providers without disruption of healthcare. Because of a dearth of literature on this topic in EoE/EGE (19), HCT programs that are tailored to these diseases must be developed and studied. Unlike other chronic diseases, there are certain aspects of healthcare that are specific to patients with EoE/EGE (19). This includes HCT not just from a single pediatric to an adult provider but transitioning to an adult multidisciplinary team including nutritionists and allergists, because patients with EoE/EGE often require a collaborative team for optimal management. In addition to medical and dietary treatment, there is also a need for serial endoscopic assessments with potential need for interventions such as dilations and biopsies that can add to the complexity of HCT.

Our study has multiple strengths and some weaknesses. First, it is the only study to have evaluated HCT knowledge and readiness in a sample of patients with EoE and/or EGE. Second, HCT readiness was measured with the disease-neutral, self-reported STARx Questionnaire, which has been shown to be a valid self-report tool with high reliability that can be used to assess transition readiness and self-management skills in adolescents/young adults with a variety of health conditions (20). Third, the study was conducted using an online survey that increases the likelihood of providing a diverse sample of EoE/EGE patients, though there could be selection bias. Those who participated in the study were most likely a highly motivated group of patients and caregivers who have access to an online interface and possibly more social support. However, in this highly selective group of activated health consumers, we would expect a higher proportion with HCT knowledge and larger readiness scores, which we did not find in our study. Therefore, it is possible that our results actually overestimate HCT knowledge in the general EoE/EGE population, highlighting an area that needs significant attention. We also did not obtain information regarding factors that affect HCT such as health insurance, race, access to resources, and education level. Since the survey was distributed through multiple online resources, we were unable to determine the overall survey response rate. In addition, provider perspectives were not collected. Finally, since the study was cross-sectional, we do not have longitudinal information regarding change in HCT readiness over time or outcomes that correlate with HCT knowledge and readiness.

In summary, approximately three-quarters of patients and parents of children with EoE/EGE who were diagnosed with the disease at ≤25 years of age were unfamiliar with health-care transition. Given our methodology, this rate of unfamiliarity may be an underestimate. In addition to the significant lack of knowledge of HCT, HCT readiness was also low compared in adolescents/young adults compared to other chronic diseases at baseline without any interventions. Given that a large cohort of EoE/EGE patients will need to transition to adult providers, HCT preparation and readiness assessments should become a priority in these patients and their parents. In addition, barriers for knowledge need to be identified to improve the process of transitioning from pediatric to adult care in the EoE/EGE population.

Supplementary Material

Supplemental Data File _doc_ pdf_ etc.__1
Supplemental Data File _doc_ pdf_ etc.__2
01

What is known:

  • - Eosinophilic esophagitis (EoE) and eosinophilic gastroenteritis (EGE) are chronic immune mediated conditions that affect both children and adolescents.

  • - Healthcare transition (HCT) needs in EoE/EGE have not been well described or formally assessed.

What is new:

  • - This is the only study to assess HCT knowledge and readiness in EoE/EGE.

  • - Knowledge of healthcare transition was lacking in more than 75% of patients with EoE/EGE and in parents of patients with these conditions.

  • - HCT readiness scores measured with the STARx Questionnaire in patients aged 13-25 years and parents were notably low compared to other chronic illnesses.

Acknowledgments

Grant Support: Funding for this analysis was supported in part by NIH award number T32 DK07634 (SE), and R01 DK101856 (ESD), as well as U54AI117804 (CEGIR), which is part of the Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Disease Research (ORDR), NCATS, and is funded through collaboration between NIAID, NIDDK, and NCATS.

Footnotes

Disclosures: None of the authors have conflicts of interested related to this article. Full disclosures are as follows:

Eluri – none

Book - none

Kodroff – none

Strobel - none

Gebhart – none

Jones – none

Menard-Katcher – none

Ferris – none

Dellon - Research funding from Meritage Pharma, Miraca Life Sciences, Receptos, Regeneron, and Shire; Consultant for Adare, Banner, Receptos, Regeneron, Roche.

Author Contributions (all authors approved the final draft):

Eluri - Project conception, study design, survey development, data collection/interpretation, data analysis, manuscript drafting, critical revision

Book - Project conception, study design, data interpretation, critical revision

Kodroff – Project conception, study design, data interpretation, critical revision

Strobel - Project conception, study design, data interpretation, critical revision

Gebhart – Study design, survey development, data collection/interpretation, critical revision

Jones – Project conception, survey development, data interpretation, critical revision

Menard-Katcher – Data interpretation, critical revision

Ferris – Project conception, study design, data interpretation, critical revision

Dellon - Project conception, study design, survey development, data interpretation, manuscript drafting, critical revision

REFERENCES

  • 1.Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3–20. e6. doi: 10.1016/j.jaci.2011.02.040. quiz 21-2. [DOI] [PubMed] [Google Scholar]
  • 2.Zuo L, Shang L, Zhang X, et al. Severe eosinophilic gastroenteritis. Gastrointest Endosc. 2016 doi: 10.1016/j.gie.2016.01.025. [DOI] [PubMed] [Google Scholar]
  • 3.Choi JS, Choi SJ, Lee KJ, et al. Clinical Manifestations and Treatment Outcomes of Eosinophilic Gastroenteritis in Children. Pediatr Gastroenterol Hepatol Nutr. 2015;18(4):253–60. doi: 10.5223/pghn.2015.18.4.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Jensen ET, Martin CF, Kappelman MD, et al. Prevalence of Eosinophilic Gastritis, Gastroenteritis, and Colitis: Estimates From a National Administrative Database. J Pediatr Gastroenterol Nutr. 2016;62(1):36–42. doi: 10.1097/MPG.0000000000000865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Reed C, Woosley JT, Dellon ES. Clinical characteristics, treatment outcomes, and resource utilization in children and adults with eosinophilic gastroenteritis. Dig Liver Dis. 2015;47(3):197–201. doi: 10.1016/j.dld.2014.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Dellon ES, Jensen ET, Martin CF, et al. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol. 2014;12(4):589–96. e1. doi: 10.1016/j.cgh.2013.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dellon ES. Epidemiology of eosinophilic esophagitis. Gastroenterol Clin North Am. 2014;43(2):201–18. doi: 10.1016/j.gtc.2014.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Spergel JM, Book WM, Mays E, et al. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr. 2011;52(3):300–6. doi: 10.1097/MPG.0b013e3181eb5a9f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Putnam PE. Eosinophilic esophagitis in children: clinical manifestations. Gastrointest Endosc Clin N Am. 2008;18(1):11–23. vii. doi: 10.1016/j.giec.2007.09.007. [DOI] [PubMed] [Google Scholar]
  • 10.Menard-Katcher P, Marks KL, Liacouras CA, et al. The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood. Aliment Pharmacol Ther. 2013;37(1):114–21. doi: 10.1111/apt.12119. [DOI] [PubMed] [Google Scholar]
  • 11.Blum RW, Garell D, Hodgman CH, et al. Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adolesc Health. 1993;14(7):570–6. doi: 10.1016/1054-139x(93)90143-d. [DOI] [PubMed] [Google Scholar]
  • 12.Callahan ST, Winitzer RF, Keenan P. Transition from pediatric to adult-oriented health care: a challenge for patients with chronic disease. Curr Opin Pediatr. 2001;13(4):310–6. doi: 10.1097/00008480-200108000-00004. [DOI] [PubMed] [Google Scholar]
  • 13.Ferris M, Cohen S, Haberman C, et al. Self-Management and Transition Readiness Assessment: Development, Reliability, and Factor Structure of the STARx Questionnaire. J Pediatr Nurs. 2015;30(5):691–9. doi: 10.1016/j.pedn.2015.05.009. [DOI] [PubMed] [Google Scholar]
  • 14.Bennett AL, Moore D, Bampton PA, et al. Outcomes and patients' perspectives of transition from paediatric to adult care in inflammatory bowel disease. World J Gastroenterol. 2016;22(8):2611–20. doi: 10.3748/wjg.v22.i8.2611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Goodhand J, Hedin CR, Croft NM, et al. Adolescents with IBD: the importance of structured transition care. J Crohns Colitis. 2011;5(6):509–19. doi: 10.1016/j.crohns.2011.03.015. [DOI] [PubMed] [Google Scholar]
  • 16.Hait E, Arnold JH, Fishman LN. Educate, communicate, anticipate-practical recommendations for transitioning adolescents with IBD to adult health care. Inflamm Bowel Dis. 2006;12(1):70–3. doi: 10.1097/01.mib.0000194182.85047.6a. [DOI] [PubMed] [Google Scholar]
  • 17.McDonagh JE. Growing up and moving on: transition from pediatric to adult care. Pediatr Transplant. 2005;9(3):364–72. doi: 10.1111/j.1399-3046.2004.00287.x. [DOI] [PubMed] [Google Scholar]
  • 18.While A, Forbes A, Ullman R, et al. Good practices that address continuity during transition from child to adult care: synthesis of the evidence. Child Care Health Dev. 2004;30(5):439–52. doi: 10.1111/j.1365-2214.2004.00440.x. [DOI] [PubMed] [Google Scholar]
  • 19.Dellon ES, Jones PD, Martin NB, et al. Health-care transition from pediatric to adult-focused gastroenterology in patients with eosinophilic esophagitis. Dis Esophagus. 2013;26(1):7–13. doi: 10.1111/j.1442-2050.2011.01315.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Cohen SE, Hooper SR, Javalkar K, et al. Self-Management and Transition Readiness Assessment: Concurrent, Predictive and Discriminant Validation of the STARx Questionnaire. J Pediatr Nurs. 2015;30(5):668–76. doi: 10.1016/j.pedn.2015.05.006. [DOI] [PubMed] [Google Scholar]
  • 21.Shaw KL, Southwood TR, McDonagh JE. Developing a programme of transitional care for adolescents with juvenile idiopathic arthritis: results of a postal survey. Rheumatology (Oxford) 2004;43(2):211–9. doi: 10.1093/rheumatology/keh018. [DOI] [PubMed] [Google Scholar]
  • 22.Dabadie A, Troadec F, Heresbach D, et al. Transition of patients with inflammatory bowel disease from pediatric to adult care. Gastroenterol Clin Biol. 2008;32(5 Pt 1):451–9. doi: 10.1016/j.gcb.2008.01.044. [DOI] [PubMed] [Google Scholar]
  • 23.Sebastian S, Jenkins H, McCartney S, et al. The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: differing perceptions from a survey of adult and paediatric gastroenterologists. J Crohns Colitis. 2012;6(8):830–44. doi: 10.1016/j.crohns.2012.01.010. [DOI] [PubMed] [Google Scholar]
  • 24.Cooley WC, Sagerman PJ. Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics. 2011;128(1):182–200. doi: 10.1542/peds.2011-0969. [DOI] [PubMed] [Google Scholar]
  • 25.Dommergues JP, Alvin P. [Transition from pediatric to adult care in severe chronic diseases in children]. Arch Pediatr. 2003;10(4):295–9. doi: 10.1016/s0929-693x(03)00041-1. [DOI] [PubMed] [Google Scholar]
  • 26.Gray WN, Holbrook E, Morgan PJ, et al. Transition readiness skills acquisition in adolescents and young adults with inflammatory bowel disease: findings from integrating assessment into clinical practice. Inflamm Bowel Dis. 2015;21(5):1125–31. doi: 10.1097/MIB.0000000000000352. [DOI] [PubMed] [Google Scholar]
  • 27.Williams CP, Smith CH, Osborn K, et al. Patient-centered approach to designing sickle cell transition education. J Pediatr Hematol Oncol. 2015;37(1):43–7. doi: 10.1097/MPH.0000000000000169. [DOI] [PubMed] [Google Scholar]
  • 28.Scal P, Evans T, Blozis S, et al. Trends in transition from pediatric to adult health care services for young adults with chronic conditions. J Adolesc Health. 1999;24(4):259–64. doi: 10.1016/s1054-139x(98)00127-x. [DOI] [PubMed] [Google Scholar]
  • 29.Katzka DA. Demographic data and symptoms of eosinophilic esophagitis in adults. Gastrointest Endosc Clin N Am. 2008;18(1):25–32. viii. doi: 10.1016/j.giec.2007.09.005. [DOI] [PubMed] [Google Scholar]
  • 30.King J, Khan S. Eosinophilic esophagitis: perspectives of adult and pediatric gastroenterologists. Dig Dis Sci. 2010;55(4):973–82. doi: 10.1007/s10620-009-0801-9. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data File _doc_ pdf_ etc.__1
Supplemental Data File _doc_ pdf_ etc.__2
01

RESOURCES